To raise awareness and provide information and support to men newly diagnosed with prostate cancer.  The foundation fosters research into better diagnostic tools and treatment options.

Cancer of the prostate is the second leading cause of male cancer death in the United States. Approximately 220,000 new cases will be diagnosed this year and nearly 30,000 men will die from the disease. Despite the gravity of a prostate cancer diagnosis, there is a surprising amount of good news to report about this disease today.

First, although statistics show prostate cancer is on the rise, we know much of this is due to a dramatic increase in early detection. Screening procedures are more common and heightened public awareness has helped more men ask their doctors to be tested. Second, extensive research in this field of medicine has lead to great advances in treatment and care of prostate cancer patients. And third, these new treatment options, the most remarkable of which is called brachytherapy have profoundly improved the standards for quality of life.

The Dattoli Cancer Foundation was established in 2000 to help increase awareness about the importance of PSA screening; to offer current, accurate information about leading edge treatment for prostate cancer; and to foster research into even better treatment options.